Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis.
AMP-Activated Protein Kinase Restricts IFN-γ Signaling.
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis.
Studies of EN-1639A (naltrexone): a new narcotic antagonist.
Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis.
Accentia Biopharmaceuticals Announces that Revimmune Autoimmune Disease Therapy is Featured in Peer-review Journal
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.
Association of SNPs rs6498169 and rs10984447 with multiple sclerosis in Saudi Patients: a model of the usefulness of familial aggregates in identifying genetic linkage in a multifactorial disease.
Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases.
Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome.
The path to self-management: a qualitative study involving older people with multiple sclerosis.
Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis.
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-beta k.o. and wild type mice.
Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER.
Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4(+) T Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis.
Self-reported incidence and age of onset of chronic comorbid medical conditions in adults aging with long-term physical disability.
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System.
1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization.
The potential for new therapeutic approaches: Global research collaboration examines multiple pathways of neuroprotection in Huntington disease
Whole-Brain Diffusion Tensor Imaging in Correlation to Visual-Evoked Potentials in Multiple Sclerosis: A Tract-Based Spatial Statistics Analysis.
Cannabinoid pharmacology: the first 66 years.
Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes.
Safety and Tolerability of Glatiramer Acetate (GLACIER)
Pages
« first
‹ previous
…
137
138
139
140
141
142
143
144
145
…
next ›
last »